Strathprints logo
Strathprints Home | Open Access | Browse | Search | User area | Copyright | Help | Library Home | SUPrimo

Evaluation of antipsychotic information on UK schizophrenia websites

Akram, G. and Boyter, A.C. and Thomson, A.H. (2010) Evaluation of antipsychotic information on UK schizophrenia websites. Psychiatrist, 34 (10). pp. 422-426.

Full text not available in this repository. (Request a copy from the Strathclyde author)

Abstract

The aim and methods of this paper are to evaluate the quality of information about medication on 33 UK schizophrenia websites using a bespoke tool known as the Strathclyde Website Evaluation Form (SWEF). The mean total SWEF score was 26 out of a maximum of 52. For website content, the mean score was 15.3 out of a maximum of 32. Most websites mentioned antipsychotics (n = 23), but only 10 described the differences between typical and atypical classes. Three websites mentioned the different injectable formulations. Information about side-effects, particularly from atypicals was limited. Comprehensive details about clozapine including the blood monitoring requirements were found on two websites. Currency was reasonable with 20 websites being less than 3 years old. Information about antipsychotic medication on UK schizophrenia websites is basic and incomplete.

Item type: Article
ID code: 26008
Notes: Formerly the Psychiatric Bulletin
Keywords: antipsychotics, websites, pharmacology, Neuroscience. Biological psychiatry. Neuropsychiatry, Therapeutics. Pharmacology, Pharmacology, Toxicology and Pharmaceutics(all)
Subjects: Medicine > Internal medicine > Neuroscience. Biological psychiatry. Neuropsychiatry
Medicine > Therapeutics. Pharmacology
Department: Faculty of Science > Strathclyde Institute of Pharmacy and Biomedical Sciences
Depositing user: Strathprints Administrator
Date Deposited: 19 Aug 2010 13:41
Last modified: 21 May 2015 12:34
URI: http://strathprints.strath.ac.uk/id/eprint/26008

Actions (login required)

View Item View Item